Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: Quantum of initial necrosis is the key

Vojnosanitetski Pregled

Volumn 66, Issue 12, 2009, Pages 998-1004

  Obradović, Slobodan ^a   Balint, Bela ^a   Romanović, Radoslav ^a   Trifunović, Zoran ^a   Rusovič, Siniša ^a   Baškot, Branislav ^a   Dopudja, Marija ^a   Trifunović, Gordana ^a   Rafajlovski, Sašo ^a   Jung, Robert ^b   Gligić, Branko ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Institute for Cardiovascular Diseases of Vojvodina   (Serbia)

Author keywords

l lactate dehydrogenase; Myocardial infarction; Regeneration; Stem cell transplantation; Treatment outcome; Ventricular disfunction, left

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; LACTATE DEHYDROGENASE;

ADULT; AGED; AGEISM; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; MALE; MONONUCLEAR CELL; OPEN STUDY; PAIN; PREDICTION; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 74249109573     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0912998O     Document Type: Article

References (15)

1. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006; 27(23): 2775-83.
2. Schachinger V, Assmus B, Britten M, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction Final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004; 44: 1690-9.
3. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months'follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113: 1287-94.
4. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-21.
5. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-209.
6. Tendera M, Wojakowski W, Ruzytto W, Chojnowska L, Kepka C, Tracz W, et al. Intracoronary infusion of bone-marrow derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of STEM Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009; 30(11): 1313-21.
7. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106(15): 1913-8.
8. Li TS, Kubo M, Ueda K, Murakami M, Mikamo A, Hamano K. Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure. J Thorac Cardiovasc Surg 2009.
9. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005; 111: 2198-202.
10. Krause K, Jaquet K, Schneider C, Haupt S, Lioznov MV, Otte KM, et al. Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study. Heart 2009; 95: 1145-152.
11. Hirata K, Hyodo E, Hozumi T, Kita R, Hirose M, Sakanoue Y, et al. Usefulness of a combination of systolic function by left ventricular ejection fraction and diastolic function by E/E' to predict prognosis in patients with heart failure. Am J Cardiol 2009; 103(9): 1275-9.
12. Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ. Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 2009; 54(7): 618-24.
13. Turan RG, Brehm M, Koestering M, Tobias Z, Bartsch T, Steiner S, et al. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Eur J Clin Invest. 2007; 37(11): 842-51.
14. Yao K, Huang R, Sun A, Qian J, Liu X, Ge L, et al. Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. Eur J Heart Fail 2009; 11(7): 691-8.
15. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006; 27(23): 2775-83.